Feedback

Your input is essential to the success of Inflammatory Bowel Disease Monitor.

We welcome your comments and suggestions on the themes covered in Inflammatory Bowel Disease Monitor, and would like to encourage your submission of articles, ideas, and suggestions for future issues.

Please take a few minutes to send us your thoughts and feedback.

 




 

 

 

 




Selected by the Editorial Board this paper has been chosen as THE paper you should read this month:
 
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn’s disease: a meta-analysis

Click here to read a critique of this paper.
Copyright © 2010 Remedica Medical Education and Publishing Disclaimer